The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence., Bizz ...
FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...
Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...
TECNIS PureSee IOL197% of patients would recommend this IOL to friends or family2TECNIS PureSee IOL is the first and only U.S. FDA-approved extended depth of focus (EDOF) IOL maintaining contrast ...
Primary IOL implantation in pediatric open globe injuries with active inflammation showed inferior visual outcomes compared ...
Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens for cataract patients. The lens is described as the first of its kind in the ...
-- Results from a 12-country survey of more than 75,000 patients shows limited patient awareness about cataract disease and available treatment options -- New findings presented at the XXXV European ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Swiss Advanced Vision (SAV-IOL) has announced the launch of Harmonis, a customizable intraocular lens (IOL) with advanced extended depth of focus (EDOF) ...
The Conversation reports cataract surgery is safe and common, with over 90% achieving 20/20 vision, but patients need to ...
Most people have a relative, friend or neighbor who has had to deal with a cataract. Nearly 24.5 million Americans age 40 or older are affected by cataracts, and it’s the leading cause of blindness ...
Pune, India-- (SBWIRE) -- 02/21/2019-- Cataract is an eye disease which causes the formation of a dense and cloudy area in the lens of the eye, mostly as a result of the aging process. Around 90% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results